Abstract

Pharmacies on the Frontline: Responding to the COVID-19 Pandemic

Author(s): McElhiney Linda F

Issue: Jul/Aug 2020 - Volume 24, Number 4

Page(s): 287-295

Download in electronic PDF format for $75
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 1
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 2
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 3
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 4
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 5
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 6
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 7
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 8
  • Pharmacies on the Frontline: Responding to the COVID-19 Pandemic Page 9

Abstract

The year 2020 will infamously be known for the COVID-19 pandemic. It certainly caught most of the population completely off-guard and forever changed their lives. Unfortunately, this pandemic is expected to make a resurgence in the fall, but hopefully more will be known about SARS-CoV-2, better treatment protocols will be established, and, possibly, a safe and effective vaccine will be developed and available soon. There are numerous drug shortages due to the COVID-19 pandemic. Some products are not commercially available in certain dosage forms needed by patients. Pharmacies (retail, independents, health systems) all over the U.S. are being asked to compound items such  as hand sanitizers, saccharin solutions for FIT testing of N95 masks, and hydroxychloroquine suspension. The commercial lopinavir/ritonavir oral liquid is in short supply and may need to be compounded soon. We are all in this one together, from the essential workers to the children, and pharmacists are emerging as one of the first-line responders.

Related Keywords

  • COVID-19 pandemic
  • coronavirus
  • SARS-CoV-2
  • drug shortages
  • hand sanitizers
  • saccharine solutions
  • FIT testing of N95 masks
  • hydroxychloroquine oral suspension
  • lopinavir
  • ritonavir
  • symptoms
  • healthcare workers
  • medical providers
  • U.S. Food and Drug Administration
  • FDA
  • temporary policies
  • testing
  • Public Readiness and Emergency Preparedness Act
  • PREP Act
  • high-risk patients
  • U.S. Occupational Safety and Health Administration
  • OSHA
  • American Pharmacists Association
  • APhA
  • specimen collection training
  • workplace safety standards
  • personal protective equipment
  • PPE
  • formulations
  • alcohol antiseptic 80% topical solution
  • topical preparations
  • isopropyl alcohol antiseptic 75% topical solution
  • remdesivir
  • drug safety
  • American Society of Health-System Pharmacists
  • ASHP
  • compounding guidelines
  • Alliance for Pharmacy Compounding
  • APC
  • Professional Compounding Centers of America
  • PCCA
  • information resources

Related Categories

  • FORMULATIONS
  • INFECTIOUS DISEASE
  • PROFESSIONAL ISSUES
  • INFORMATION RESOURCES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2020
Pg. 287-295
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
Author(s): McElhiney Linda F
Jan/Feb 2023
Pg. 12-21
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Author(s): Riepl Mike
May/Jun 2023
Pg. 192-200
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Author(s): Riepl Mike, Kaiser Joe
Jul/Aug 2020
Pg. 268
PreScription: COVID-19 and Compounding Pharmacists
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 284-293
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Author(s): Riepl Mike, Kaiser Joe
Sep/Oct 2023
Pg. 368-380
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Author(s): Riepl Mike, Kaiser Joe
Mar/Apr 2023
Pg. 98-107
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Author(s): Riepl Mike
Sep/Oct 2020
Pg. 358-364
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Author(s): Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Mar/Apr 2021
Pg. 109-113
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Jul/Aug 2020
Pg. 316
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 100-109
Allowing Compounding Pharmacies to Address Drug Shortages
Author(s): Broughel James
Jul/Aug 2021
Pg. 268
PreScription: Endemics, Epidemics, and Pandemics
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 310
Calculations
Author(s): Stockton Shelly J
Nov/Dec 2019
Pg. 467-471
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Jul/Aug 2021
Pg. 296-297
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Author(s): Brunner Scott
Jul/Aug 2011
Pg. 278-284
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy
Author(s): Mixon William, Wood Adam P, Low Jennifer, Homan Linda
Sep/Oct 2021
Pg. 386-387
It's Time for a New Philosophy
Author(s): Brunner Scott
Sep/Oct 2019
Pg. 387-391
Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1
Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Jul/Aug 2013
Pg. 307-311
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
Author(s): McElhiney Linda F
Mar/Apr 2011
Pg. 92
PreScription: Discontinued Drugs and Drug Shortages
Author(s): Allen Loyd V Jr